Ellevest Inc’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.78M | Sell |
3,180
-94
| -3% | -$96K | 0.45% | 35 |
|
|
2026
Q1 | $3.01M | Buy |
3,274
+57
| +2% | +$57.8K | 0.42% | 35 |
|
|
2025
Q4 | $3.46M | Sell |
3,217
-52
| -2% | -$49.7K | 0.48% | 33 |
|
|
2025
Q3 | $2.49M | Sell |
3,269
-252
| -7% | -$188K | 0.36% | 36 |
|
|
2025
Q2 | $2.74M | Sell |
3,521
-60
| -2% | -$46.6K | 0.44% | 33 |
|
|
2025
Q1 | $2.96M | Buy |
3,581
+2
| +0.1% | +$1.66K | 0.2% | 41 |
|
|
2024
Q4 | $2.76M | Sell |
3,579
-221
| -6% | -$183K | 0.16% | 46 |
|
|
2024
Q3 | $3.37M | Buy |
3,800
+38
| +1% | +$34.2K | 0.19% | 41 |
|
|
2024
Q2 | $3.41M | Buy |
3,762
+261
| +7% | +$209K | 0.2% | 40 |
|
|
2024
Q1 | $2.72M | Buy |
3,501
+87
| +3% | +$61.9K | 0.17% | 47 |
|
|
2023
Q4 | $1.99M | Buy |
3,414
+591
| +21% | +$345K | 0.14% | 50 |
|
|
2023
Q3 | $1.52M | Buy |
2,823
+80
| +3% | +$41.2K | 0.12% | 53 |
|
|
2023
Q2 | $1.29M | Buy |
2,743
+170
| +7% | +$71.3K | 0.1% | 56 |
|
|
2023
Q1 | $884K | Buy |
2,573
+78
| +3% | +$26.3K | 0.07% | 68 |
|
|
2022
Q4 | $913K | Buy |
2,495
+215
| +9% | +$76.2K | 0.08% | 69 |
|
|
2022
Q3 | $737K | Buy |
2,280
+217
| +11% | +$68.8K | 0.07% | 64 |
|
|
2022
Q2 | $669K | Buy |
2,063
+1,487
| +258% | +$446K | 0.06% | 76 |
|
|
2022
Q1 | $165K | Sell |
576
-1,173
| -67% | -$302K | 0.01% | 340 |
|
|
2021
Q4 | $483K | Buy |
1,749
+1,213
| +226% | +$307K | 0.04% | 111 |
|
|
2021
Q3 | $124K | Buy |
536
+43
| +9% | +$10.6K | 0.01% | 354 |
|
|
2021
Q2 | $113K | Sell |
493
-1,194
| -71% | -$240K | 0.01% | 354 |
|
|
2021
Q1 | $315K | Buy |
1,687
+125
| +8% | +$24.5K | 0.04% | 123 |
|
|
2020
Q4 | $264K | Buy |
1,562
+403
| +35% | +$60.2K | 0.04% | 125 |
|
|
2020
Q3 | $172K | Buy |
1,159
+54
| +5% | +$8.36K | 0.03% | 146 |
|
|
2020
Q2 | $181K | Buy |
1,105
+418
| +61% | +$64.2K | 0.04% | 125 |
|
|
2020
Q1 | $95K | Buy |
687
+211
| +44% | +$29K | 0.03% | 147 |
|
|
2019
Q4 | $63K | Buy |
476
+261
| +121% | +$30.3K | 0.02% | 148 |
|
|
2019
Q3 | $24K | Buy |
215
+20
| +10% | +$2.23K | 0.01% | 170 |
|
|
2019
Q2 | $22K | Buy |
195
+106
| +119% | +$12.5K | 0.01% | 191 |
|
|
2019
Q1 | $12K | Hold |
89
| – | – | 0.01% | 179 |
|
|
2018
Q4 | $10K | Buy |
+89
| New | +$9.94K | 0.01% | 380 |
|
Other funds holding LLY
Ellevest Inc's LLY Position: Q2 2026 in Review
Ellevest Inc reduced its Eli Lilly (LLY) stake by 2.9% in Q2 2026, selling an estimated $96K and leaving 3,180 shares worth $3.78M. The position accounts for 0.45% of the portfolio, ranked #35.
Ellevest Inc first reported a position in LLY in Q4 2018 and has held it in 31 quarters since. 4,630 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Ellevest Inc held 3,180 shares of Eli Lilly worth $3.78M as of Q2 2026.
- Ellevest Inc sold 94 Eli Lilly shares in Q2 2026, an estimated $96K.
- Eli Lilly made up 0.45% of Ellevest Inc's portfolio in Q2 2026, its #35 holding.
- Ellevest Inc first reported a position in Eli Lilly in Q4 2018 and has held it in 31 quarters since.
- 4,630 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Ellevest Inc's 13F filing for Q2 2026, filed 10 Aug 2026.